PDE9A
Basic information
Region (hg38): 21:42653621-42775509
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PDE9A gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 43 | 49 | ||||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 0 | |||||
Total | 0 | 0 | 43 | 6 | 1 |
Variants in PDE9A
This is a list of pathogenic ClinVar variants found in the PDE9A region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
21-42653873-G-A | not specified | Uncertain significance (May 03, 2023) | ||
21-42686205-A-C | not specified | Uncertain significance (Jan 02, 2024) | ||
21-42686229-T-G | not specified | Uncertain significance (Mar 25, 2024) | ||
21-42687923-G-A | not specified | Likely benign (Oct 10, 2023) | ||
21-42687944-C-T | not specified | Likely benign (Jan 09, 2024) | ||
21-42687945-G-A | not specified | Uncertain significance (Aug 30, 2021) | ||
21-42687947-C-T | not specified | Likely benign (Mar 16, 2024) | ||
21-42687948-G-A | not specified | Uncertain significance (Jun 02, 2023) | ||
21-42687951-G-A | not specified | Uncertain significance (Sep 15, 2021) | ||
21-42687966-G-A | not specified | Uncertain significance (Aug 17, 2021) | ||
21-42698974-G-A | not specified | Likely benign (Jun 13, 2023) | ||
21-42698987-C-G | not specified | Uncertain significance (Oct 17, 2023) | ||
21-42731800-G-A | not specified | Uncertain significance (Jan 06, 2023) | ||
21-42731818-G-C | not specified | Uncertain significance (Jan 19, 2024) | ||
21-42731859-C-T | not specified | Uncertain significance (Jun 07, 2022) | ||
21-42732093-G-A | not specified | Uncertain significance (Jul 13, 2022) | ||
21-42732105-G-A | not specified | Uncertain significance (Apr 28, 2023) | ||
21-42733369-A-G | not specified | Uncertain significance (Oct 13, 2023) | ||
21-42733418-G-A | not specified | Uncertain significance (Jan 26, 2022) | ||
21-42743784-C-A | not specified | Uncertain significance (Aug 04, 2023) | ||
21-42743785-T-C | not specified | Uncertain significance (Nov 10, 2022) | ||
21-42743818-A-G | not specified | Uncertain significance (Jan 23, 2024) | ||
21-42751168-C-T | not specified | Uncertain significance (Jun 04, 2024) | ||
21-42751177-G-A | not specified | Uncertain significance (Oct 03, 2022) | ||
21-42751186-A-G | not specified | Uncertain significance (Aug 10, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PDE9A | protein_coding | protein_coding | ENST00000291539 | 20 | 121874 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00456 | 0.995 | 125719 | 0 | 29 | 125748 | 0.000115 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.09 | 307 | 365 | 0.840 | 0.0000221 | 3945 |
Missense in Polyphen | 81 | 114.1 | 0.70988 | 1230 | ||
Synonymous | 0.482 | 133 | 140 | 0.948 | 0.00000962 | 1044 |
Loss of Function | 4.11 | 12 | 40.1 | 0.300 | 0.00000213 | 440 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000271 | 0.000271 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000384 | 0.000381 |
Finnish | 0.000139 | 0.000139 |
European (Non-Finnish) | 0.0000706 | 0.0000703 |
Middle Eastern | 0.000384 | 0.000381 |
South Asian | 0.000131 | 0.000131 |
Other | 0.000164 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Specifically hydrolyzes the second messenger cGMP, which is a key regulator of many important physiological processes. Highly specific: compared to other members of the cyclic nucleotide phosphodiesterase family, has the highest affinity and selectivity for cGMP (PubMed:9624146, PubMed:18757755, PubMed:21483814). Specifically regulates natriuretic-peptide- dependent cGMP signaling in heart, acting as a regulator of cardiac hypertrophy in myocytes and muscle. Does not regulate nitric oxide-dependent cGMP in heart (PubMed:25799991). Additional experiments are required to confirm whether its ability to hydrolyze natriuretic-peptide-dependent cGMP is specific to heart or is a general feature of the protein (Probable). In brain, involved in cognitive function, such as learning and long-term memory (By similarity). {ECO:0000250|UniProtKB:Q8QZV1, ECO:0000269|PubMed:18757755, ECO:0000269|PubMed:21483814, ECO:0000269|PubMed:25799991, ECO:0000269|PubMed:9624146, ECO:0000305}.;
- Pathway
- Purine metabolism - Homo sapiens (human);Phosphodiesterases in neuronal function;Purine nucleotides nucleosides metabolism;Hemostasis;cGMP effects;Nitric oxide stimulates guanylate cyclase;Platelet homeostasis;Regulation of Androgen receptor activity
(Consensus)
Recessive Scores
- pRec
- 0.126
Intolerance Scores
- loftool
- 0.262
- rvis_EVS
- -0.46
- rvis_percentile_EVS
- 23.63
Haploinsufficiency Scores
- pHI
- 0.455
- hipred
- Y
- hipred_score
- 0.585
- ghis
- 0.486
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.974
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Pde9a
- Phenotype
- homeostasis/metabolism phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan);
Gene ontology
- Biological process
- signal transduction;positive regulation of cardiac muscle hypertrophy;cGMP-mediated signaling;cGMP metabolic process;cGMP catabolic process
- Cellular component
- endoplasmic reticulum;Golgi apparatus;cytosol;ruffle membrane;sarcolemma;perikaryon;perinuclear region of cytoplasm
- Molecular function
- 3',5'-cyclic-nucleotide phosphodiesterase activity;protein binding;metal ion binding;3',5'-cyclic-GMP phosphodiesterase activity